Screener
Cytokinetics CYTK Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Cytokinetics’s reported figures.
Based on trailing twelve months.
The source filing: Cytokinetics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:30 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338217
FAQ
- What is Cytokinetics's free cash flow margin?
- Cytokinetics (CYTK) reported free cash flow margin of -858.2% in Q2 2026.
- How has Cytokinetics's free cash flow margin changed year-over-year?
- Cytokinetics's free cash flow margin decreased by 67.7% year-over-year, from -511.7% to -858.2%.
- What is the long-term trend for Cytokinetics's free cash flow margin?
- Over 4 years (2021 to 2025), Cytokinetics's free cash flow margin has grown at a 22.3% compound annual growth rate (CAGR), from -271.8% to -607.5%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.
Ask your AI about Cytokinetics's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude